These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23973720)

  • 1. Infantile parkinsonism and GABAergic hypotransmission in a patient with pyruvate carboxylase deficiency.
    Ortez C; Jou C; Cortès-Saladelafont E; Moreno J; Pérez A; Ormazábal A; Pérez-Cerdá C; Pérez B; Artuch R; Cusi V; García-Cazorla A
    Gene; 2013 Dec; 532(2):302-6. PubMed ID: 23973720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects.
    García-Cazorla A; Rabier D; Touati G; Chadefaux-Vekemans B; Marsac C; de Lonlay P; Saudubray JM
    Ann Neurol; 2006 Jan; 59(1):121-7. PubMed ID: 16278852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorders of pyruvate metabolism.
    De Meirleir L
    Handb Clin Neurol; 2013; 113():1667-73. PubMed ID: 23622387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate carboxylase deficiency: prenatal onset of ischemia-like brain lesions in two sibs with the acute neonatal form.
    Brun N; Robitaille Y; Grignon A; Robinson BH; Mitchell GA; Lambert M
    Am J Med Genet; 1999 May; 84(2):94-101. PubMed ID: 10323732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pyruvate carboxylase deficiency with atypical clinical and neuroradiological presentation.
    Schiff M; Levrat V; Acquaviva C; Vianey-Saban C; Rolland MO; Guffon N
    Mol Genet Metab; 2006 Feb; 87(2):175-7. PubMed ID: 16325442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
    Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
    J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of a fetal brain affected by a severe form of tyrosine hydroxylase deficiency, a rare cause of early parkinsonism.
    Tristán-Noguero A; Díez H; Jou C; Pineda M; Ormazábal A; Sánchez A; Artuch R; Garcia-Cazorla À
    Metab Brain Dis; 2016 Jun; 31(3):705-9. PubMed ID: 26686676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate carboxylase deficiency: acute exacerbation after ACTH treatment of infantile spasms.
    Rutledge SL; Snead OC; Kelly DR; Kerr DS; Swann JW; Spink DL; Martin DL
    Pediatr Neurol; 1989; 5(4):249-52. PubMed ID: 2553027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons.
    González-Hernández T; Barroso-Chinea P; Acevedo A; Salido E; Rodríguez M
    Eur J Neurosci; 2001 Jan; 13(1):57-67. PubMed ID: 11135004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the subthalamic nucleus upon the damage to the dopamine system following lesions of globus pallidus in rats.
    Wright AK; Arbuthnott GW
    Eur J Neurosci; 2007 Aug; 26(3):642-8. PubMed ID: 17634067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic GAD gene therapy in a Parkinson's disease rat model.
    Luo J; Kaplitt MG; Fitzsimons HL; Zuzga DS; Liu Y; Oshinsky ML; During MJ
    Science; 2002 Oct; 298(5592):425-9. PubMed ID: 12376704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defects of pyruvate metabolism and the Krebs cycle.
    De Meirleir L
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S26-33; discussion 3S33-4. PubMed ID: 12597053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy.
    Mochel F; DeLonlay P; Touati G; Brunengraber H; Kinman RP; Rabier D; Roe CR; Saudubray JM
    Mol Genet Metab; 2005 Apr; 84(4):305-12. PubMed ID: 15781190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
    Marin-Valencia I; Roe CR; Pascual JM
    Mol Genet Metab; 2010 Sep; 101(1):9-17. PubMed ID: 20598931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamatergic pallidothalamic projections and their implications in the pathophysiology of Parkinson's disease.
    Barroso-Chinea P; Rico AJ; Pérez-Manso M; Roda E; López IP; Luis-Ravelo D; Lanciego JL
    Neurobiol Dis; 2008 Sep; 31(3):422-32. PubMed ID: 18598767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic release of dopamine in the subthalamic nucleus.
    Cragg SJ; Baufreton J; Xue Y; Bolam JP; Bevan MD
    Eur J Neurosci; 2004 Oct; 20(7):1788-802. PubMed ID: 15380000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyruvate Carboxylase Deficiency Type C: A Rare Cause of Acute Transient Flaccid Paralysis with Ketoacidosis.
    Almomen M; Sinclair G; Stockler-Ipsiroglu SG; Horvath GA
    Neuropediatrics; 2018 Dec; 49(6):369-372. PubMed ID: 30045381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
    Wang YQ; Bian GL; Bai Y; Cao R; Chen LW
    Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.